436 related articles for article (PubMed ID: 25929935)
21. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.
Mauri D; Polyzos NP; Salanti G; Pavlidis N; Ioannidis JP
J Natl Cancer Inst; 2008 Dec; 100(24):1780-91. PubMed ID: 19066278
[TBL] [Abstract][Full Text] [Related]
22. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
[TBL] [Abstract][Full Text] [Related]
23. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571
[TBL] [Abstract][Full Text] [Related]
24. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.
Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y
Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients.
Ozdemir N; Aksoy S; Sendur MA; Akinci MB; Yazici O; Budakoglu B; Abali H; Oksuzoglu B; Zengin N
J BUON; 2013; 18(4):831-7. PubMed ID: 24344005
[TBL] [Abstract][Full Text] [Related]
26. Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
Zhang J; Gu SY; Gan Y; Wang ZH; Wang BY; Guo HY; Wang JL; Wang LP; Zhao XM; Hu XC
Cancer Chemother Pharmacol; 2013 Jan; 71(1):103-13. PubMed ID: 23053266
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.
Burzykowski T; Buyse M; Piccart-Gebhart MJ; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1987-92. PubMed ID: 18421050
[TBL] [Abstract][Full Text] [Related]
28. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effectiveness of Taxane-Containing Regimens for Treatment of HER2-Negative Metastatic Breast Cancer: A Network Meta-analysis.
Dong L; Zhu LN; Xie BJ; Li JB; Ding T; Jiang YF; Zhu ZN
Pharmacotherapy; 2019 Dec; 39(12):1126-1136. PubMed ID: 31692005
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.
Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M
J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135
[TBL] [Abstract][Full Text] [Related]
31. A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
Anand K; Niravath P; Patel T; Ensor J; Rodriguez A; Boone T; Wong ST; Chang JC
Clin Breast Cancer; 2021 Jun; 21(3):199-204. PubMed ID: 34159901
[TBL] [Abstract][Full Text] [Related]
32. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma.
Bria E; Giannarelli D; Felici A; Peters WP; Nisticò C; Vanni B; Cuppone F; Cognetti F; Terzoli E
Cancer; 2005 Feb; 103(4):672-9. PubMed ID: 15637696
[TBL] [Abstract][Full Text] [Related]
33. Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Poggio F; Ceppi M; de Azambuja E; Lambertini M
Breast Cancer Res Treat; 2019 Feb; 174(1):27-37. PubMed ID: 30465156
[TBL] [Abstract][Full Text] [Related]
34. Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis.
Wang S; Deng L; Chen J; Li Y; Zhong Y; Wang Y; Cao H
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17671-17682. PubMed ID: 37891407
[TBL] [Abstract][Full Text] [Related]
35. Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer.
Chen W; Tu Q; Shen Y; Tang K; Hong M; Shen Y
World J Surg Oncol; 2021 Feb; 19(1):52. PubMed ID: 33602236
[TBL] [Abstract][Full Text] [Related]
36. Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.
Campone M; Cortes-Funes H; Vorobiof D; Martin M; Slabber CF; Ciruelos E; Bourbouloux E; Mendiola C; Delgado FM; Colin C; Aslanis V; Fumoleau P
Br J Cancer; 2006 Nov; 95(9):1161-6. PubMed ID: 17031408
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of doublet versus single agent as salvage treatment for metastatic breast cancer pretreated with anthracyclines and taxanes: a systematic review and meta-analysis.
Zhang T; Wang R; Liu Y; Huang J; Yang Z
Curr Med Res Opin; 2016 Nov; 32(11):1883-1889. PubMed ID: 27489049
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials.
Xu L; Wu X; Hu C; Zhang Z; Zhang L; Liang S; Xu Y; Zhang F
Onco Targets Ther; 2016; 9():4061-74. PubMed ID: 27445497
[TBL] [Abstract][Full Text] [Related]
39. First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.
Jiang Y; Yin W; Zhou L; Yan T; Zhou Q; Du Y; Shen Z; Shao Z; Lu J
PLoS One; 2012; 7(3):e32474. PubMed ID: 22396769
[TBL] [Abstract][Full Text] [Related]
40. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
Cochrane Database Syst Rev; 2013 Jul; (7):CD008909. PubMed ID: 23832787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
